REVISTAT
Manufacturer Details
INTRA LABS
INTRA LABS INDIA PVT LTD
#43/44 P.S.Lane
B.R.D.Building
Chickpet Cross
Bengaluru 560053
intralabs@yahoo.com
Compositions:
Ethamsylate 250mg/500mg tablets,
Ethamsylate 250mg/2ml injection,
|
Strength
|
Rate
|
Packing Style
|
|
250mg
|
55.00
|
10s tablets
|
|
500mg
|
75.00
|
10s tablets
|
|
250mg/2ml
|
21.00
|
2ml injection
|
List of Related Indications:
List Of Drugs:
- Ethamsylate - Haemostatics(May 1988)
Indication Type Description:
Drug Interaction:
Not available
Indication:
Menorrhagia
Control of hemorrhage after surgery
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Ethamsylate Anti-haemostatic May 1988
Adverse Reaction:
Transient hypotension(withi.v.inj). Headache,nausea, skin rash.
Contra-Indications:
Hypersensitive to the drug.Pregnancy,lactation.
Special precautions:
1st trimester of pregnancy,patients with acute porphyria.
Dosages/ Overdosage Etc:
Date of Approval 1988
Menorrhagia
Control of hemorrhage after surgery
Adult- 250 - 500mg every 6 hours as needed.
May also be given via IV/IM inj
Interaction with Food:
Not available
Pregnancy and lactation:
Contraindicated for use during pregnancy and lactation
